MFAP4 has been suggested to be actively involved in the pathogenesis of several matrix remodelling-associated diseases, such as liver cirrhosis, cardiovascular disorders, and cancer, through its interactions with integrins and proinflammatory signalling, as well as modulating the TGF-β pathway [31,32]. The gene discussed is MFAP4; the disease is cancer.